vorasidenib
servier
['vorasidenib']
vorasidenib is potential first targeted therapy for low-grade glioma #asco23
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more